Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
The FDA updated a warning on the label of esketamine nasal spray (Spravato) about the long-term cognitive ... for agitation ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers.
New research offers hope for delaying Alzheimer’s disease progression by years after initial diagnosis. Alzheimer’s disease is a leading cause of death among those aged 65 or older. As the most common ...
Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...